World Of Taxonomy
50242-051Level 3

Rituxan (rituximab)

**Product type:** Human Prescription Drug

**Active ingredient:** RITUXIMAB

**Strength:** 10 mg/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA103705)

**Pharmacologic class:** CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]

GET/api/v1/systems/ndc_fda/nodes/50242-051
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.